EDIT:NASDAQ
Editas Medicine Inc
2,57 USD
arrow_upward
+0,78%(+0,020) 1D
2,57 USD
0,00% (0,00)
bedtimeNakon radnog vremena
Zatvoreno: 6. stu, 16:00:01 GMT -5 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za EDIT...
Otvori
2,55 USD
Najviša
2,63 USD
Najniža
2,48 USD
Trž. kap.
394,70 mil.
Prosj. kol.
2,33 mil.
Količina
1,72 mil.
52-tjed. najviša
3,94 USD
52-tjed. najniža
1,66 USD
EPS
−0,74 USD
Beta
2,09
Dionice u optjecaju
153,58 mil.
Broj djelatnika
87
Otvori
2,55 USD
Najviša
2,63 USD
Najniža
2,48 USD
Trž. kap.
394,70 mil.
Prosj. kol.
2,33 mil.
Količina
1,72 mil.
52-tjed. najviša
3,94 USD
52-tjed. najniža
1,66 USD
EPS
−0,74 USD
Beta
2,09
Dionice u optjecaju
153,58 mil.
Broj djelatnika
87
Vijesti
Iz web-izvora i od partnera za vijesti
24/7 Wall St.
·
prije 28 minuta
Bitcoin's Correlation With the S&P 500 Just Hit 0.80. Is Bitcoin Trading Like a Tech Stock Again?
Cryptonews.net
·
prije 1 sat
XRP Price Prediction: Analyst Warns of $0.80 Crash if S&P 500 Breaks Key Support
Benzinga
·
prije 4 sata
Dow Jones and S&P 500 Outlook: Stock Market News To Watch This Week
IndexBox
·
prije 34 minute
Capital Economics Warns AI Investment Boom Is Fading, Sees S&P 500 Falling 12% by End of 2027
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc – informacije
Glavni izvršni direktor-
Zaposlenici87
Osnovanostu 2013
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijaeditasmedicine.com